NCT02191657View on ClinicalTrials.gov

Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

April 30, 2010

Conditions
HIV Infection
Interventions
DRUG

Deferiprone

Oral iron chelator

Trial Locations (1)

9324

PAREXEL International, Bloemfontein

Sponsors

Lead Sponsor

ApoPharma
All Listed Sponsors
lead

ApoPharma

INDUSTRY

NCT02191657 - Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects | Biotech Hunter | Biotech Hunter